PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis
ConditionMenstrual Bleeding, Heavy
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorOregon Health and Science University
About this trial
The purpose of the study is to learn more about the role of blood clotting factor proteins and cells in menstrual (period) bleeding. The investigators are hoping to identify differences in these proteins and cells in the menstrual blood of individuals with heavy periods compared to menstruating individuals who do not have heavy periods.
Eligibility criteria
Qualifiers
Regularly menstruating participants between 18-45 years of age
Disqualifiers
Pregnancy within 3 months of enrollment
Lactating at the time of enrollment
Hormonal contraceptive use or use of the copper intrauterine device (IUD)
Antifibrinolytic use
Trial design
Treatments tested in this trial
- Sample Collection and Endometrial Biopsy
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov